INTRODUCTION
Proteoglycan polymorphism is a well-established concept. Distinct gene products have been characterized as proteoglycan cores. New developments concerning the potential roles of proteoglycan have emerged: they are now thought not only to be involved in hydrodynamic or structural roles in tissues, but also to be implicated in various regulatory effects (Ruoslahti, 1988 (Ruoslahti, , 1989 . In the testis, peritubular cells and Sertoli cells have been shown to act co-operatively in co-culture to synthesize different components of an extracellular matrix (Tung & Fritz, 1980; ; the latter regulates testicular cord formation and germ cell development in vitro (Hadley et al., 1985) . It has been suggested that the synthesis of some of its components, namely proteoglycans, is an age-related process which probably plays an active role in spermatogenesis (Rodriguez & Minguell, 1989a) . Somatic rat testicular cells secrete two types of proteoglycans: one containing both heparan/chondroitin, the other chondroitin/dermatan sulphate as glycosaminoglycan chains Rodriguez & Minguell, 1989b) . Proteoglycans from rat peritubular cells and Sertoli cells have been partially characterized, mainly as a function of the nature of the glycosaminoglycan side-chains which they bear . Molecular characterization of the proteoglycans present in the seminal plasma is lacking. The aim of this work was to characterize, at a molecular level, the proteoglycans in human seminal plasma.
EXPERIMENTAL Materials
The chromatographic media, namely Mono Q (HR 5/5 column) and Superose 6 (HR 10/30 column), were obtained from Pharmacia (Uppsala, Sweden); they were fitted to the Pharmacia f.p. 
Preparative procedures
Human seminal plasma was prepared from ejaculates of healthy donors according to Guess et al. (1986) . Seminal plasma was mixed with 2 vol. of extracting buffer [6 M-guanidinium hydrochloride (Gdn-HCl)/50 mM-sodium acetate, pH 5.8, containing S mM-benzamidine, 10 mM-6-aminohexanoic acid, and 10 mM-EDTA as protease inhibitors]. Extraction was carried out for 2 h at 4°C with constant stirring, the supernatant was recovered after centrifugation at 1500 g for 15 min and the pellet was extracted twice, for 15 min, with 10 ml of 4.5 M-GdnHCl/50 mM-sodium acetate, pH 5.8, containing the protease inhibitors. Solid CsCl was added to the pooled extracts up to a density of 1.45 g/ml. The mixture was submitted to densitygradient centrifugation for 40 h at 20°C (35000 rev./min in a Beckman L8-55 ultracentrifuge, 60 Ti rotor). Eight fractions were collected from the gradient and exhaustively dialysed against distilled water in the presence of the protease inhibitors listed above. The hexuronate-containing fractions were mixed with an equal volume of 7.6 M-urea/50 mM-Tris/HCl buffer, pH 7.6, (buffer A) and applied to a Mono Q HR 5/5 column equilibrated in buffer A. The column was washed with 0.3 M-NaCl/buffer A; elution was performed with a linear 95 ml NaCl gradient (0.3-1.5 M) in buffer A (at a flow rate of 0.5 ml/min).
The hexuronate-containing fractions were pooled, diluted with 4 vol. of buffer A and applied to a Q-Sepharose column (2 cm x 0.4 cm) equilibrated in the same buffer. Washings (5 ml) were carried out with 0.05 M-Tris/HCl buffer, pH 7.6, hexuronates were eluted with 6 M-Gdn-HCl and precipitated by the addition of 4 vol. of cold ethanol (20 h, -20°C & Von Jagow (1987) , and scintillation measurements were carried out after solubilization of gel slices (10 mm3) in 30 % (w/v) hydrogen peroxide according to Tishler & Epstein (1968) .
Superose 6 gel filtration was carried out in buffer B on an HR 10/30 column, at a flow rate of 0.5 ml/min; in this experiment, proteoglycans were detected by a slot-blot assay: adsorption was performed in 10 % (w/v) acetic acid on Hybond-N+ membranes (Amersham International, Aylesbury, Bucks., U.K.) followed by Toluidine Blue staining. TSK HW-55(F) gel filtrations were performed on a column (0.3 cm x 22 cm) using buffer B as eluent; fractions (120 1l) were collected and analysed by scintillation measurements; TSK HW-40(S) gel filtrations for the removal of Gdn-HCl after TSK HW-55(F) filtration were performed on a column of the same size in a 50 mM-ammonium acetate, pH 8, buffer. N-Terminal amino-acid sequences were determined with an Applied Biosystems 470 A sequencer equipped with a model 120 phenylthiohydantoin (PTH) analyser; 14C-labelled S-carboxymethylcysteine PTH-derivatives were identified by scintillation measurement (Kontron Instruments, Montigny, France; , counter).
Chondroitinase ABC and heparinase III digestions were carried out at 37°C over 4 h in 40 ,ul of a 1 mM-CaCl2/50 mMsodium acetate (pH 7.5) buffer containing 50 mM-6-aminohexanoic acid, 5 mM-benzamidine hydrochloride and 1 mmphenylmethanesulphonyl fluoride as protease inhibitors, with 5 x 10-3 enzyme unit/,tg of hexuronate.
RESULTS

Purification of S.GP
Upon dissociative CsCl-gradient centrifugation of human seminal plasma extract, 95 % of the hexuronate was recovered in the bottom quarter of the gradient. By this procedure 20 ejaculates yielded 400 + 25,g of hexuronate in this fraction, which was then applied on the Mono Q column equilibrated in buffer A. After washing of the column with 20 ml of 0.3 MNaCl/buffer A, hexuronates mainly eluted between 0.65-0.85 MNaCl; this material was termed S.GP (Fig. 1) . The first minor eluted peak (0.6 M-NaCl) was not further studied.
On composite polyacrylamide/agarose gels, S.GP behaved as a single broad band, the electrophoretic mobility of which was similar to that of human platelet proteoglycan (Perin et al., 1988) , but consistently different from rat chondrosarcoma proteoglycan (Oegema et al., 1975) and free chondroitin sulphate chains (Fig. 2) .
['4C]Iodoacetamide was used to form reduced and alkylated S.GP (RA-S.GP). After this treatment hexuronates were detected in a broad peak and eluted from a Superose 6 column (Kay 0.3) (slot-dot assay detection); this purified fraction, termed RA-S.GP-II, contained 80 % of the incorporated radioactivity (Fig. 3) . On SDS/PAGE the radiolabelled, purified RA-S.GP-II co-migrated with the Toluidine-Blue-stained product (results not shown). with both enzymes resulted in an almost total disappearance of the Toluidine Blue staining (Fig. 4) . This result indicates that both chondroitin and heparan sulphate chains are present in the S.GP fraction, and that chondroitin sulphate is the major glycosaminoglycan.
Identification of the RA-S.GP protein core A set of two analytical experiments was carried out to characterize the RA-S.GP protein core.
In the first series of experiments, reduced and 14C-labelled carboxymethylated S.GP was purified by Q-Sepharose ionexchange chromatography. This material, containing both RA-S.GP-I and RA-S.GP-II, was submitted to various enzymic deglycosylation experiments and the resulting products were analysed by TSK HW-55(F) gel filtration (Fig. 5) . When compared with the untreated sample (Ka, y 0.3), chondroitinase treatment resulted in an extensive broadening of the peak containing the radiolabelled material, while upon heparinase III treatment, the elution profile was less affected. Additionally, after combined treatment with both enzymes, a new peak (KayV 0.6-0.8) was characterized. However, a significant portion of the radiolabelled material still eluted at a position similar to that of the untreated sample (fraction I in Fig. 5) ; this material could not be shifted towards a lower molecular mass species even after an additional deglycosylation attempt. On SDS/PAGE, fraction I in Fig. 5 was shown to contain two different entities of % 94 kDa and . 45 kDa (Fig. 6a) . The material eluted at a Kav for Superose-6-purified RA-S.GP-II ( 
where ? represents an unidentified amino acid.
The Q/A ratio in step 2 was 52/48, but the level of PTH derivatives belonging to the (b) sequence dropped after step 4. Even when further purified by Superose 6 gel filtration, a nonreduced and non-alkylated sample still gave rise to these two Nterminal amino-acid sequences. Identical results were obtained when three different subfractions of S.GP (I, II and III in Fig. 1 ) were subjected to recurrent Edman degradation. Identical results were also obtained for a preparation carried out from a whole semen sample which had been immediately frozen after collection. (12) Thr (10) Gly (10) Asp (6) Phe (6) Gly (8) Gly (5) Gly (5) Ser (5) Val (3) * Cys was identified as an S-carboxymethyl derivative in position 7 by scintillation measurement. 0.6-0.8 (fraction in Fig. 5 ) and behaved as a lower molecular mass compound in the 18 kDa range (Fig. 6a) . From these results, the 18 kDa fragment, which was only detected after chondroitinase ABC/heparinase III treatment, was suspected to be derived from a chondroitin/heparan-bearing polypeptide. Its identity was ascertained by a second experiment, using RA-S.GP-II purified using Superose 6. After combined treatment with both chondroitinase ABC and heparinase III, this fraction only gave rise to the 18 kDa species on SDS/PAGE (Fig. 6b) .
Identification of the N-terminal amino-acid sequences of S.GP and RA-S.GP-II A unique N-terminal amino-acid sequence was characterized DISCUSSION This work was initiated to characterize, at a molecular level, proteoglycans present in human seminal plasma; all the results reported in this study are consistent with the statement that this biological fluid contains a glycosaminoglycan-bearing polypeptide (S.GP) as the major proteoglycan entity.
As a function of deglycosylation experiments, the occurrence of both heparan and chondroitin sulphate has been shown in the purified S.GP, as well as in RA-S.GP-II.
From this set of experiments, it appeared that the 'KQGA ....
' polypeptide, previously characterized in Superose-6-purified RA-S.GP-II, consists of a peptidic core bearing chondroitinase ABC/heparinase III-sensitive glycosaminoglycan side-chains. However, as chondroitinase treatment alone gave rise to a low amount of material in the peak II Kv. range (Fig. Sb) , the possibility that some RA-S.GP only contains chondroitin sulphate has to be considered.
Two glycosylation sites can be postulated in positions 14 and 19 in the RA-S.GP-II N-terminal sequence. The surrounding amino acids fit well with the general consensus sequence E/D-X-S-G for a glycosaminoglycan linkage, involving a serine residue; X represents one or perhaps two amino acids and either a hydrophobic or small neutral residue (Bourdon, 1990 ). Thus we propose to assign serine residues to positions 14 and 19 (see Table 1 ); as a consequence RA-S.GP-II could contain two clustered glycosaminoglycan-attachment sites. One of them, ETSGDF, (underlined serine residue corresponds to a glycosaminoglycan linkage) closely resembles the ETSGEN sequence, which was suggested to be a heparan sulphate-attachment site in murine syndecan (Saunders et al., 1989) . The other, DFSGG, does not share the constant feature of such a site (i.e. an acidic amino-acid residue on the C-terminus side of SG); it therefore could be relevant to a chondroitin-sulphate-bearing site. However, these assumptions remain to be confirmed as only a few glycosylation sites, corresponding to chondroitin/dermatan sulphate chains, have so far been clearly demonstrated, the others still being speculative (Bourdon, 1990 (b) 568 Human seminal plasma glycosaminoglycan-bearing polypeptide 1988) and serglycin (Tantravahi et al., 1986) , depending on the cellular type.
S.GP was isolated to a degree of purity allowing the determination of a single N-terminal amino-acid sequence of its reduced and alkylated form (RA-S.GP-II). However, two Nterminal sequences were characterized for a non-reduced sample. Contamination of the S.GP preparation by a foreign protein can be ruled out as a function of the preparative procedure used in this work: recovery in a fraction of density > 1.5 g/ml after density-gradient centrifugation, high acidic characteristic during anionic exchange chromatography. Several observations: (i) the equimolar ratio of Q/A at step 2 during protein sequencing of a non-reduced sample; (ii) the characterization of the KATQ...... sequence in three different pools of S.GP (I, II and III in Fig. 1) ; and (iii) its loss after reduction and alkylation, are indicative that the KATQ...... entity did not bear glycosaminoglycan sidechains but represents a short peptidic moiety, bound via cysteine residue(s) to the KQGA...... material. Preliminary studies, dealing with cDNA cloning, reveal the presence of these two amino-acid sequences on a single protein core (P. M. Alliel, J. P. Perin, P. Jolles and F. Bonnet, unpublished work). A search in the National Biomedical Research Foundation protein database revealed that the RA-S.GP-II sequence had no significant sequence similarity with any protein described so far.
Particular care has been taken to include protease inhibitors up to the Mono Q purification step in order to avoid proteolytic degradation of the material during the preparative procedure. In addition, both preparations carried out on seminal plasma and whole semen, immediately frozen after collection, gave rise to the same N-terminal amino-acid sequences. The possibility that S.GP consists of an ejaculated glycosaminoglycan-bearing region, arising from a larger proteoglycan proteolytically processed in the genital tract, should therefore be considered.
